Docstoc

Innate Immunotherapeutics Completes $10M IPO

Document Sample
Innate Immunotherapeutics Completes $10M IPO Powered By Docstoc
					
				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:6
posted:12/18/2013
language:Japanese
pages:3
Description: SYDNEY--(BUSINESS WIRE)--Innate Immunotherapeutics is pleased to announce it has successfully raised A$10 million through its Initial Public Offer (IPO) and will immediately commence planning its clinical trial for MIS416.
EON: Enhanced Online News EON: Enhanced Online News http://eon.businesswire.com
About At EON: Enhanced Online News, we show you how to make your online press release thrive. If you want to drive traffic to your website, generate sales leads, make an announcement, or promote a new product, EON: Enhanced Online News delivers the online visibility that you need. EON: Enhanced Online News powered by Business Wire.